165 related articles for article (PubMed ID: 13899710)
1. Species differences in the cardiac effects of a monoamine oxidase inhibitor.
GOLDBERG ND; SHIDEMAN FE
J Pharmacol Exp Ther; 1962 May; 136():142-51. PubMed ID: 13899710
[No Abstract] [Full Text] [Related]
2. The role of monoamine oxidase in the cardiac accumulation of norepinephrine.
Lee WC; Yoo CS
Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):221-36. PubMed ID: 6055131
[No Abstract] [Full Text] [Related]
3. EFFECT OF VARIOUS MONOAMINE OXIDASE INHIBITORS ON THE CATECHOLAMINE CONTENT OF RAT HEART.
BHAGAT B
Arch Int Pharmacodyn Ther; 1963 Nov; 146():65-72. PubMed ID: 14078525
[No Abstract] [Full Text] [Related]
4. [The effect of the monoamine oxidase inhibitor iproniazio on fat metabolism and catecholamine dynamics in tissues].
Menisov AK
Vopr Med Khim; 1973; 19(2):134-5. PubMed ID: 4707503
[No Abstract] [Full Text] [Related]
5. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
GREEN H; SAWYER JL
J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
[No Abstract] [Full Text] [Related]
6. Inhibition of monoamine oxidase activity in sympathetic ganglia of the cat.
LEVINE RJ
Biochem Pharmacol; 1962; 11():395-6. PubMed ID: 14464650
[No Abstract] [Full Text] [Related]
7. Monoamine oxidase and inhibitors.
Goergen K
Humangenetik; 1970; 9(3):205-6. PubMed ID: 5451683
[No Abstract] [Full Text] [Related]
8. Facilitation of metrazol-in-duced seizures by iproniazid and betaphenylisopropylhy-drazine in mice.
SPOERLEIN MT; ELLMAN AM
Arch Int Pharmacodyn Ther; 1961; 133():193-9. PubMed ID: 13915887
[No Abstract] [Full Text] [Related]
9. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
Maître L
J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
[No Abstract] [Full Text] [Related]
10. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
Mirzoian RS
Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
[No Abstract] [Full Text] [Related]
11. [Apropos of iproniazid. Inhibition of monoamine oxidase in therapy].
HOLZER J; SOLIGNAC H
Prod Pharm; 1961 Oct; 16():482-4. PubMed ID: 13908637
[No Abstract] [Full Text] [Related]
12. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
Gomes B
Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
[No Abstract] [Full Text] [Related]
13. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
ZELLER EA; SARKAR S
J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
[No Abstract] [Full Text] [Related]
14. [Effect of iproniazid on the tremor caused by some 2-substituted derivatives of tryptamine].
Ostrovskaia RU
Farmakol Toksikol; 1966; 29(6):668-72. PubMed ID: 6000363
[No Abstract] [Full Text] [Related]
15. Vascular hypersensitivity and potentiation of catecholamines induced by monoamine oxidase inhibition.
Balourdas TA
Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):275-88. PubMed ID: 5926870
[No Abstract] [Full Text] [Related]
16. [Cardiac catecholamines after ligation of the coronary artery. Influence of a monoaminoxidase inhibitor (nialamide) on the infarct].
SERRANO PA; VILLANUEVA SA; LERDO DE TEJADAHAY A; CASTANEDA Y; CHAVEZ LARA B; BISTENI A
Arch Inst Cardiol Mex; 1961; 31():197-204. PubMed ID: 13910885
[No Abstract] [Full Text] [Related]
17. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
SPECTOR S; SHORE PA; BRODIE BB
J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
[No Abstract] [Full Text] [Related]
18. [EFFECT OF CHANGES IN MEDIATOR METABOLISM ON THE DEVELOPMENT OF HEART HYPERTROPHY].
MEERSON FZ; ROZANOVA LS
Biull Eksp Biol Med; 1964 Mar; 57():34-7. PubMed ID: 14185598
[No Abstract] [Full Text] [Related]
19. [Experimental animal research on the mechanism of the narcosis-shortening action of monoamine oxidase inhibitors].
WESTERMANN E; STOCK K
Chemotherapia (Basel); 1962; 4():329-39. PubMed ID: 14006333
[No Abstract] [Full Text] [Related]
20. [Preliminary tests of the action of an MAO inhibitor (Iproniazid) on iris motility].
Balacco-Gabrieli C
Boll Soc Ital Biol Sper; 1971 Jan; 47(2):36-8. PubMed ID: 5088816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
